PASSAGE BIO INC. - COMMON STOCK

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

20 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

17 ноя 2023 16:30:00 Источник Nasdaq GlobeNewswire

Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

13 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference

30 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20 окт 2023 16:30:00 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference

25 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights

07 авг 2023 07:15:54 Источник Nasdaq GlobeNewswire

Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study

07 авг 2023 07:00:12 Источник Nasdaq GlobeNewswire

Passage Bio to Participate in Upcoming Investor Conferences

01 авг 2023 07:00:49 Источник Nasdaq GlobeNewswire

Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors

31 июл 2023 07:00:59 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference

05 июн 2023 07:00:09 Источник Nasdaq GlobeNewswire

Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights

11 май 2023 07:00:50 Источник Nasdaq GlobeNewswire

Passage Bio Announces Recipient of Second Annual Tachi Yamada Scholarship Award

04 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 апр 2023 16:01:17 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

17 апр 2023 07:00:35 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days

27 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights

06 мар 2023 07:00:41 Источник Nasdaq GlobeNewswire

Passage Bio Seeks Pennsylvania College Student Candidates for Second Annual Tachi Yamada Scholarship Program

01 мар 2023 07:00:02 Источник Nasdaq GlobeNewswire

Passage Bio to Present at Cowen 43rd Annual Health Care Conference

28 фев 2023 07:00:37 Источник Nasdaq GlobeNewswire

Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023

27 фев 2023 07:00:37 Источник Nasdaq GlobeNewswire